External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience
- 1 February 2018
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 37, 36-41
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of HER2 status on distant recurrence in early stage breast cancerBreast Cancer Research and Treatment, 2012
- Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guidelinePractical Radiation Oncology, 2012
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesJournal of Clinical Oncology, 2012
- Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)Annals of Oncology, 2009
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerCancer, 2008
- A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG DatabaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Breast Cancer Metastasis to the Central Nervous SystemThe American Journal of Pathology, 2005
- CNS Metastases in Breast CancerJournal of Clinical Oncology, 2004
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997